Sanofi SA (LTS:0A2V)
$ 49 0 (0%) Market Cap: 122.85 Bil Enterprise Value: 141.18 Bil PE Ratio: 28.19 PB Ratio: 1.63 GF Score: 87/100

Sanofi SA at JPMorgan Healthcare Conference Transcript

Jan 10, 2023 / NTS GMT
Release Date Price: $48.38 (+0.80%)
Richard Vosser
JPMorgan Chase & Co, Research Division - Senior Analyst

Welcome to the Sanofi presentation at the 41st JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst at JPMorgan, and it's my great pleasure to introduce Paul Hudson, the CEO of Sanofi.

Before I hand over to Paul, just to remind everyone, we will take Q&A after Paul's presentation in this room. Please put your hand up and wait for a microphone, and then we'll take your question. Paul, welcome to the conference.

Paul Hudson
Sanofi - CEO & Director

Okay. Thank you, Richard. Thank you. Can you hear me okay? What a wonderful and warm introduction, Richard, thank you very much for that. It's 3 years since that we've been here together at least, and it used to be the big room, I think, and then a scramble to get to the small room for the Q&A. I think I prefer this already. So let's see how far we get.

In those 3 years, an awful lot has happened for us at Sanofi. We've really been on our journey, really transforming the company, really

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot